H-2Ld MuLV gp70 Tetramer-SPSYVYHQF-PE

Zhang, L., Jiang, L., Yu, L. et al. Inhibition of UBA6 by inosine augments tumour immunogenicity and responses. Nat Commun 13, 5413 (2022). https://doi.org/10.1038/s41467-022-33116-z

Agarwal, Yash, et al. “Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity.” Nature Biomedical Engineering 6.2 (2022): 129-143.

Zúñiga, Luis Alejandro, et al. “Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction.” Cancer Cell International 22.1 (2022): 1-17.

Herrador-Cañete, Guillermo, et al. “Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.” Molecular Therapy-Oncolytics 26 (2022): 246-264.

Sivick KE et al. Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity. Cell Rep. 25, 3074-3085.e5 (2018)